Picture of Lumibird SA logo

LBIRD — Lumibird SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Lumibird Receives Marketing Approval In China For Its Vitra 2 Photocoagulator

April 17 (Reuters) - Lumibird SA  LBIRD.PA :
    * LUMIBIRD RECEIVES MARKETING APPROVAL IN CHINA FOR ITS
VITRA 2
PHOTOCOAGULATOR
    * FOR YEAR 2023, LAUNCH OF VITRA 2 ALONE SHOULD ENABLE US TO
INCREASE OUR SALES BY 25%, COMPARED TO A REVENUE OF EUR 4.8
MILLION IN CHINA IN 2022 - CEO OF LUMIBIRD MEDICAL

Source text for Eikon:  ID:nGNE6BqDpK 
Further company coverage:  LBIRD.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Lumibird SA

See all news